Daily electronic self-monitoring of subjective and objective symptoms in bipolar disorder—the MONARCA trial protocol (MONitoring, treAtment and pRediCtion of bipolAr disorder episodes): a randomised controlled single-blind trial

• Published in: BMJ open Vol. 3; no. 7; p. e003353
• Main Authors: Faurholt-Jepsen, Maria, Vinberg, Maj, Christensen, Ellen Margrethe, Frost, Mads, Bardram, Jakob, Kessing, Lars Vedel
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.01.2013; BMJ Publishing Group
• Subjects: Bipolar disorder; Clinical medicine; Feedback; Illnesses; Intervention; Mental Health; Quality of life; Questionnaires; Smartphones; Software; Denmark; Medical Education & Training; Mental Health
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2013-003353

Introduction Electronic self-monitoring of affective symptoms using cell phones is suggested as a practical and inexpensive way to monitor illness activity and identify early signs of affective symptoms. It has never been tested in a randomised clinical trial whether electronic self-monitoring improves outcomes in bipolar disorder. We are conducting a trial testing the effect of using a Smartphone for self-monitoring in bipolar disorder. Methods We developed the MONARCA application for Android-based Smartphones, allowing patients suffering from bipolar disorder to do daily self-monitoring—including an interactive feedback loop between patients and clinicians through a web-based interface. The effect of the application was tested in a parallel-group, single-blind randomised controlled trial so far including 78 patients suffering from bipolar disorder in the age group 18–60 years who were given the use of a Smartphone with the MONARCA application (intervention group) or to the use of a cell phone without the application (placebo group) during a 6-month study period. The study was carried out from September 2011. The outcomes were changes in affective symptoms (primary), social functioning, perceived stress, self-rated depressive and manic symptoms, quality of life, adherence to medication, stress and cognitive functioning (secondary and tertiary). Analysis Recruitment is ongoing. Ethics Ethical permission has been obtained. Dissemination Positive, neutral and negative findings of the study will be published. Registration details The trial is approved by the Regional Ethics Committee in The Capital Region of Denmark (H-2-2011-056) and The Danish Data Protection Agency (2013-41-1710). The trial is registered at ClinicalTrials.gov as NCT01446406.